Physician
Pediatric Endocrinology
Dr. Eric A. Simone, MD
|
|
Give Review
Eric Simone practices Pediatric Endocrinology. He attended University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3 in research and 3 in primary care medicine Eric A. Simone, MD is also a published physician. He has 21 publication published. The most recent publication is: Genotypic and phenotypic characterization of six new recombinant congenic strains derived from NOD/Shi and CBA/J genomes.
Publications
- Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase.
- Loading PEG-catalase into filamentous and spherical polymer nanocarriers.
- Effect of polymer amphiphilicity on loading of a therapeutic enzyme into protective filamentous and spherical polymer nanocarriers.
- T cell receptor restriction of diabetogenic autoimmune NOD T cells.
- Chronic autoimmunity of type I diabetes.
- Adult height in thalassaemia major without hormonal treatment.
- Reference frame effects on shape perception in two versus three dimensions.
- Chloride-sulphate exchange chemically measured in human erythrocyte ghosts.
- Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse.
- Immunologic "vaccination" for the prevention of autoimmune diabetes (type 1A).
- Genotypic and phenotypic characterization of six new recombinant congenic strains derived from NOD/Shi and CBA/J genomes.
- T cell receptor gene polymorphisms associated with anti-insulin, autoimmune T cells in diabetes-prone NOD mice.
- Polymeric carriers: role of geometry in drug delivery.
- Nanocarriers for vascular delivery of antioxidants.
- Endothelial targeting of antibody-decorated polymeric filomicelles.
- Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies.
- Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.
- Targeted delivery of therapeutics to endothelium.
- Delivery of acid sphingomyelinase in normal and niemann-pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers.
- Synthesis and characterization of polymer nanocarriers for the targeted delivery of therapeutic enzymes.
Schools
University of California At San Francisco
Conditions Treated
- Abnormal Thyroid
- Adrenogenital Disorders
- Hyperlipidemia
Doctors Specialties
- Pediatric Endocrinology
Accepted Insurances
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Choice Health PPO
- Group Health Cooperative
- Humana
- Medicare MCR
- Molina
- ODS Health Plan
- Heritage Plus
- Heritage Signature
- Providence Health Plans
- Preferred Provider Network PPN
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Education
-
University of Colorado -
Johns Hopkins University -
University of California San Francisco School of Medicine
Hospital
-
Swedish Medical Center-Cherry Hill Campus
Helpful Reviews
Similar Doctors
|
|
Dr. Parisa Salehi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ildiko Hrabovszky Koves, MD |
|
|
Dr. Catherine Pihoker, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David M. Werny, MD |
|
|
Dr. Carolina Di Blasi, MD |
|
|
Dr. Faisal S. Malik, MD |
|
|
Dr. Kalyani R. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Srinath Sanda, MD |